MyFinsight
Home
Blog
About
Contact
Download
Download image
Cash and cash
equivalents
$13,196,033
Prepaid expenses and
other current assets
$842,432
Total current assets
$14,038,465
Property, plant &
equipment, net
$549,405
Operating lease
right-of-use asset
$360,671
Other long-term
assets
$29,780
Total assets
$14,978,321
Total liabilities and
stockholders' equity
$14,978,321
Total stockholders'
equity
$8,537,164
Total liabilities
$5,059,134
Series d convertible
preferred stock, 111.11...
$1,382,023
Accumulated deficit
-$269,133,500
Additional paid-in capital
$277,149,844
Total current
liabilities
$4,749,737
Lease liability, net
of current portion
$309,397
Series e-2 preferred
stock, 1,225.00 shares...
$520,778
Common stock, 0.00001
par value...
$42
Accounts payable and
accrued liabilities
$4,423,548
Warrant liability
$226,000
Lease liability,
current
$100,189
Back
Back
Balance Sheet
source: myfinsight.com
Cellectar Biosciences, Inc. (CLRB)
Cellectar Biosciences, Inc. (CLRB)